EP0037583A1 - Méthode pour la détermination fluorométrique de l'activité des enzymes dégradant les graisses et moyens pour sa réalisation - Google Patents
Méthode pour la détermination fluorométrique de l'activité des enzymes dégradant les graisses et moyens pour sa réalisation Download PDFInfo
- Publication number
- EP0037583A1 EP0037583A1 EP81102650A EP81102650A EP0037583A1 EP 0037583 A1 EP0037583 A1 EP 0037583A1 EP 81102650 A EP81102650 A EP 81102650A EP 81102650 A EP81102650 A EP 81102650A EP 0037583 A1 EP0037583 A1 EP 0037583A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- group
- groups
- acyl
- fluorescent
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 34
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 26
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 26
- 230000000694 effects Effects 0.000 title claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims abstract description 39
- 239000000758 substrate Substances 0.000 claims abstract description 23
- 238000010791 quenching Methods 0.000 claims abstract description 14
- 230000000171 quenching effect Effects 0.000 claims abstract description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol Substances OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 37
- 125000002252 acyl group Chemical group 0.000 claims description 19
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 claims description 14
- -1 phosphoryl group Chemical group 0.000 claims description 12
- 239000000178 monomer Substances 0.000 claims description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 9
- 230000005284 excitation Effects 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical group NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical group OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Chemical group OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical group C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 3
- 229960001231 choline Drugs 0.000 claims description 3
- 125000004417 unsaturated alkyl group Chemical group 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- 150000001721 carbon Chemical group 0.000 claims 2
- 150000002431 hydrogen Chemical group 0.000 claims 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 102000015439 Phospholipases Human genes 0.000 abstract description 15
- 108010064785 Phospholipases Proteins 0.000 abstract description 15
- 102000004882 Lipase Human genes 0.000 abstract description 11
- 108090001060 Lipase Proteins 0.000 abstract description 11
- 239000004367 Lipase Substances 0.000 abstract description 11
- 235000019421 lipase Nutrition 0.000 abstract description 11
- 210000002966 serum Anatomy 0.000 abstract description 9
- 238000006911 enzymatic reaction Methods 0.000 abstract description 7
- 125000005581 pyrene group Chemical group 0.000 abstract description 2
- 229940088598 enzyme Drugs 0.000 description 14
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 12
- 235000011187 glycerol Nutrition 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 9
- 150000004665 fatty acids Chemical class 0.000 description 9
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 235000021588 free fatty acids Nutrition 0.000 description 7
- 229940040461 lipase Drugs 0.000 description 7
- 150000003904 phospholipids Chemical class 0.000 description 7
- 238000003556 assay Methods 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 229950004354 phosphorylcholine Drugs 0.000 description 6
- 230000002255 enzymatic effect Effects 0.000 description 5
- 239000007850 fluorescent dye Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 102000019280 Pancreatic lipases Human genes 0.000 description 3
- 108050006759 Pancreatic lipases Proteins 0.000 description 3
- 229940009976 deoxycholate Drugs 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229940116369 pancreatic lipase Drugs 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- HAUGRYOERYOXHX-UHFFFAOYSA-N Alloxazine Chemical compound C1=CC=C2N=C(C(=O)NC(=O)N3)C3=NC2=C1 HAUGRYOERYOXHX-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- BHQCQFFYRZLCQQ-OELDTZBJSA-M cholate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-M 0.000 description 2
- 229940099352 cholate Drugs 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical compound C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 description 2
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 2
- 150000002314 glycerols Chemical class 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 235000019626 lipase activity Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 125000001725 pyrenyl group Chemical group 0.000 description 2
- JNELGWHKGNBSMD-UHFFFAOYSA-N xanthone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3OC2=C1 JNELGWHKGNBSMD-UHFFFAOYSA-N 0.000 description 2
- RIWAPWDHHMWTRA-UHFFFAOYSA-N 1,2,3-triiodobenzene Chemical compound IC1=CC=CC(I)=C1I RIWAPWDHHMWTRA-UHFFFAOYSA-N 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
- VUPXKQHLZATXTR-UHFFFAOYSA-N 2,4-diphenyl-1,3-oxazole Chemical compound C=1OC(C=2C=CC=CC=2)=NC=1C1=CC=CC=C1 VUPXKQHLZATXTR-UHFFFAOYSA-N 0.000 description 1
- KLLLJCACIRKBDT-UHFFFAOYSA-N 2-phenyl-1H-indole Chemical compound N1C2=CC=CC=C2C=C1C1=CC=CC=C1 KLLLJCACIRKBDT-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- HTDLSAGEOYDVSJ-UHFFFAOYSA-N 4-phenyloxadiazole Chemical compound O1N=NC(C=2C=CC=CC=2)=C1 HTDLSAGEOYDVSJ-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- FOVOSQIGVKWZFK-UHFFFAOYSA-N OBO.C1=CC=CC=C1 Chemical compound OBO.C1=CC=CC=C1 FOVOSQIGVKWZFK-UHFFFAOYSA-N 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- XBDYBAVJXHJMNQ-UHFFFAOYSA-N Tetrahydroanthracene Natural products C1=CC=C2C=C(CCCC3)C3=CC2=C1 XBDYBAVJXHJMNQ-UHFFFAOYSA-N 0.000 description 1
- DSNRWDQKZIEDDB-GCMPNPAFSA-N [(2r)-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-[(z)-octadec-9-enoyl]oxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C/CCCCCCCC DSNRWDQKZIEDDB-GCMPNPAFSA-N 0.000 description 1
- YKVCMFSQLMIPJX-CLFAGFIQSA-N [2-(6-bromohexanoyloxy)-3-[(z)-octadec-9-enoyl]oxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCBr)COC(=O)CCCCCCC\C=C/CCCCCCCC YKVCMFSQLMIPJX-CLFAGFIQSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000012801 analytical assay Methods 0.000 description 1
- JRXXLCKWQFKACW-UHFFFAOYSA-N biphenylacetylene Chemical group C1=CC=CC=C1C#CC1=CC=CC=C1 JRXXLCKWQFKACW-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910052801 chlorine Chemical group 0.000 description 1
- 239000000460 chlorine Chemical group 0.000 description 1
- 239000002642 cobra venom Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 150000001982 diacylglycerols Chemical class 0.000 description 1
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 239000008344 egg yolk phospholipid Substances 0.000 description 1
- YLQWCDOCJODRMT-UHFFFAOYSA-N fluoren-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C2=C1 YLQWCDOCJODRMT-UHFFFAOYSA-N 0.000 description 1
- 238000007421 fluorometric assay Methods 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N glycerol 1-phosphate Chemical class OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- LIIALPBMIOVAHH-UHFFFAOYSA-N herniarin Chemical compound C1=CC(=O)OC2=CC(OC)=CC=C21 LIIALPBMIOVAHH-UHFFFAOYSA-N 0.000 description 1
- JHGVLAHJJNKSAW-UHFFFAOYSA-N herniarin Natural products C1CC(=O)OC2=CC(OC)=CC=C21 JHGVLAHJJNKSAW-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000009878 intermolecular interaction Effects 0.000 description 1
- 239000011630 iodine Chemical group 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 230000001000 lipidemic effect Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- ZLQJVGSVJRBUNL-UHFFFAOYSA-N methylumbelliferone Natural products C1=C(O)C=C2OC(=O)C(C)=CC2=C1 ZLQJVGSVJRBUNL-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 1
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- IWELDVXSEVIIGI-UHFFFAOYSA-N piperazin-2-one Chemical compound O=C1CNCCN1 IWELDVXSEVIIGI-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- IFLREYGFSNHWGE-UHFFFAOYSA-N tetracene Chemical compound C1=CC=CC2=CC3=CC4=CC=CC=C4C=C3C=C21 IFLREYGFSNHWGE-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/61—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving triglycerides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2334/00—O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
- G01N2333/918—Carboxylic ester hydrolases (3.1.1)
Definitions
- the object of the present invention is a clinico- analytical assay method which is based on changes occurring in the fluorescence intensity.
- One such method is lipase and phospholipase, especially phospholipase A 2 assay in serum.
- Lipases are enzymes which split triacyl-glycerols into free fatty acids, glycerides and glycerol. Lipases differ from each other i.a. as to their stereospecificity, and some lipases have the ability to distinguish between the fatty acids in the 1- and 3-positions of an sn-triacyl- glycerol.
- Phospholipase A 2 splits the fatty acid in the 2-position with respect to the phosphoryl group of a phospholipid, the end products being a lysophospholipid and a free fatty acid.
- lipase and phospholipase enzymes which under normal conditions are released into the gastrc-intestinal tract. I.a. in connection with pancreatitis these enzymes, however, are released into the blood stream and consequently it is of diagnostical importance to measure the enzyme activity in the plasma.
- the assay methods for phospholipases have been based on the use of a radioactive substrate, whereby e.g. C- or 3 H -atoms are introduced into the fatty acid in the 2-position and the degree of radioactivity of the fatty acid split by the phospholipase A 2 is measured.
- the method is however cumbersome because of the many stages involved, and it requires special apparatuses, i.a. a scintillation counter.
- the object of the present invention is to provide a fluorometric assay method wherein substrates containing glycerol and phosphoglycerol compounds are used, into which compounds fluorescent groups have been introduced, and optionally also quencher groups, and wherein the changes in the fluorescence intensity due to the enzymatic reaction are measured.
- the object of the present invention is thus a method for fluorometrically measuring the activity of fat-degrading enzymes in samples containing said enzyme according to which method the enzyme containing sample is combined with a substrate which contains an acyl- or an acyl-alkyl-glycerol or -phosphoglycerol which reacts with the enzyme to be assayed, wherein at least one of the acyl or alkyl groups contains a fluorescent group and the other groups may optionally contain a fluorescence quenching group, the substrate is excited at the specific excitation wave-length of the fluorescent group in question and the change, due to the enzyme, in the fluorescence intensity of the substrate per time unit is measured at a specific emission wave length of the fluorescent group, the rate of change being directly proportional to the enzyme activity in the sample.
- the fluorescent group may be pyrene, tetracene, anthracene, phenanthrene, naphthalene, coumarone, coumarin, acridine, benzocarbazone, aminonaphtalenesulfonic acid, mono-, di- or tri-iodo-benzene, perylene, phenyloxadi- azole, diphenyloxazole, alloxazine, stilbene, dibenzo- furan, fluorene, fluorenone, oxopiperazine, p-quinone, methylumbelliferone, phenazine, phenyl-indole, quinoline, di-ethylaniline, phenol, diphenylacetylene, benzotiophen, pyrimidine, xanthone, thiocarbocyanide, 1,3,5,7-deka- tetra-ene.
- a suitable fluorescent group is pyrene because of its well-characterized fluorescence behaviour (Th. Forster, Angew. Chem. 81, 364 (1969) and S.C. Charlton et al, The Journal of Biol. Chem. Vol. 251, No 24, 7952 (1976)).
- the fluorescence may be sensitized when using compounds of the formula I containing two fluorescent groups, by introducing into one of them electron donating groups such as methyl, methoxy, hydroxyl or dimethylamino groups, and into the other electron attracting groups, such as cyano and nitro groups.
- electron donating groups such as methyl, methoxy, hydroxyl or dimethylamino groups
- other electron attracting groups such as cyano and nitro groups.
- halogen such as bromine, iodine or chlorine, or halogen substituted groups, such as halogen substituted phenyl groups.
- a first sub group a) of the compounds of the formula I comprises for lipase assay suitable triacyl-, diacyl- monoalkyl- and diacyl-glycerols, respectively, wherein at least one of the acyl and alkyl groups is substituted with a fluorescent group, and wherein one other or both the other groups may be substituted with a fluorescence quenching group.
- triacyl-glycerols or the formula I wherein one, two or all three acyl groups may contain one, two or three fluorescent groups, suitably pyrene groups, as well as 1,3-diacyl-2-alkyl-sn-glycerols, which can be substituted with fluorescent groups as the triacyl-glycerols.
- Usable intramolecularly quenched compounds of this group are for example triacyl- or l,3-diacyl-2-alkyl-sn- glycerols which in their 2-position contain a fluorescent group, whereby the quenching group, suitably a bromine group, is in the 1- and/or 3-position.
- the second sub group b) comprises phospholipid compounds suitable for phospholipase A 2 assay and having the formula wherein in the formula Ia the group R 2 and in the formula I b the group R 1 is an afore mentioned acyl group, and wherein at least one of the groups Rand R , or R 1 and R 3 , respectively, contains a fluorescent group, and the other optionally a quenching group.
- 1,2-diacyl-or l-alkyl-2-acyl-compounds of formula Ia wherein one or both of the groups in the positions 1 and 2 contains a fluorescent group.
- a suitable compound is also the corresponding compound wherein the fluorescent group has been quenched with a bromine or iodine atom or with some other halogen containing group.
- a compound which contains a single fluorescent group
- such a compound forms when emulsified in oil, whereby the individual molecules are packed close together, a so-called intermolecular dimer, i.e. an excimer, which, when excited. at the excitation wave- length of the fluorescent group in question, fluoresces at the excimer wavelength characteristic for this group.
- the above mentioned compound I 1-oleoyl-2-(4-(3-pyrenyl)-buturoyl)-3-oleoyl-sn-glycerol, forms emulsified in oil, an intermolecular excimer, which, when excited at the excitation wavelength of about 320-345 nm, fluoresces at the excimer wavelength of 470 nm of pyrene.
- an emulsion reacts with pancreatic lipase there is formed, because the pancreatic lipase does not exhibit stereospecificity, two free fatty acids and 2-(4-(3-pyrenyl)-buturoyl)-glycerol.
- the change in fluorescence intensity may be followed either at the excimer wavelength of pyrene of ca 470 nm or at its monomer wavelength of ca 390 to 400 nm, and the rate of change of the intensity is directly proportional to the amount of fluorescent compound degraded by the enzyme, i.e..to the enzymatic activity.
- a strongly fluorescent intramolecular excimer is formed by compounds of the formula I which in the same molecule contain two or three fluorescent groups. As a result of the enzymatic reaction the interaction between these fluorescent groups gradually disappears, whereby the excimer fluorescence intensity decreases and correspondingly.the monomer fluorescence intensity increases.
- the phospholipase A 2 hydrolyzes the fatty acid chain in the 2-position and as reaction products a fluorescent free fatty acid and a fluorescent pyrene-fatty acid phosphatide are formed.
- the pyrene excimer fluorescence at the wavelength of about 470 nm weakens and its monomer fluorescence at the wave- length of about 400 nm increases, and the rate of change of the fluorescence intensity is proportional to the degree of hydrolyzis.
- the rate of change of the fluorescence intensity it is possible to determine the amount of fluorescent compound degraded per time unit, which in turn is dependent on the enzymatic activity.
- the enzymatic activity can be measured also by using according to the invention a compound which contains both a fluorescent as well as a group, or groups, preferably bromine atoms, quenching the intramolecular fluorescence.
- a fatty acid containing either a fluorescent group or a quenching group is split off and a fluorescent fatty acid or a fluorescent glycerol compound is formed which fluoresces at the monomer wavelength.
- the increase in intensity, due to a lesser degree of quenching, is enhanced by the same phenomenon as when using a compound containing only one fluorescent group.
- the method may be carried out also by using an oil-emulsified substrate containing both a compound having one fluorescent group and a compound which contains a fluorescence quenching group.
- oil these compounds are forced into close contact thus forming a so-called intramolecularly quenched macromolecule, which as a result of the enzymatic reaction is broken down into products which fluoresce at the monomer wavelength.
- An object of the invention are also the compounds usable for carrying out the method according to the invention, especially the compounds of formula I, as new substances.
- These compounds may be prepared e.g. by introducing into glycerol or D-mannitol the desired acyl and alkyl substituents, optionally containing fluorescent or quencher groups. The substituted D-mannitol is then split and reduced to the corresponding glycerol. A substituted glycerol thus obtained may be further substituted in its free position with a phosphoryl group or a derivative thereof to obtain the desired compound.
- Phospholipase A 2 activity was measured using the following phospholipid substrate which in 2.90 ml contains
- the fluorescence was measured with a Perkin-Elmer-fluorescense- spektrofotometer, excitation opening 3 nm, emission opening 6 nm, excitation wavelength 320 nm, emission wavelength 470 nm.
- the base level was determined whereafter 100 ⁇ l of a sample containing phospholipase A 2 from cobra venom was added to the substrate.
- the lipase activity was measured using the following lipid substrate
- the fluorescence was measured using a fluorescence spectrofotometer connected to a recorder, excitation opening 20 nm, emission opening 20 nm, excitation wave- length 343 nm. Emission was folled at the wavelength 400 nm. First the base level was measured whereafter 50 ⁇ l of a sample containing lipase was added and the increase in fluorescence intensity per time unit was followed at the monomer wavelength of ca 400 nm.
- Fig. 2 is shown an assay with normal and pathological serum.
- the fluorescence intensity Im was measured at the monomer wavelength 400 nm as a function of time.
- fluorescent compound the above 1-oleoyl-2-(4-(3-pyrenyl)-buturoyl-3-oleoyl-sn-glycerol was used. Benzene boronate was used for stopping the a reaction.
- Example 2 may be repeated but using as an intramolecularly quenched compound 1 ⁇ g of 1-(6-bromohexanoyl) - 2-(4-(3-pyrenyl)-buturoyl)-3-oleoyl-sn-glycerol and measuring the increase in fluorescence intensity per time unit, as above.
- the phospholipase A 2 activity was measured using a substrate which in 2.0 ml contains
- phospholipids As phospholipids the following compounds may be used:
- the lecithin and the fluorescent compound were dried solvent free in a nitrogen stream. Thereafter the Na-deoxycholate was added and the mixture sonicated using a Branson sonifier equipped with microtip at setting 4. Thereafter the bovine serum albumin was added, dissolved in buffer. The substrate was stable for several day provided 0.1 mM NaN 3 was added to prevent microbial growth.
- Fluorescence changes were measured using a Kontron SFM-23 spectrofluorometer equipped with a magnetically stirred cell (1.0 x 1.0 x 0.5 cm). Temperature was controlled with a cryostat at 37 0 C throughout the measurement. The fluorescence intensity signal was fed into a recorder. Excitation wavelength was 343 nm for the pyrenyl containing compounds and 370 nm for the anthroyl containing compounds, and the changes in the monomer fluorescence intensity were followed 400 nm for pyrenyl and at 450 nm for anthroyl.
- the lipase activity was measured using a substrate which in 2.0 ml contains
- the lipid to be tested was dried in a stream of nitrogen whereafter the tributyrin and detergents were added, as well as the buffer solution, whereafter the mixture was sonified as in Example 3.
- the sample a was to be stored 0.1 mM of NaN 3 was added to prevent microbial growth.
- the substrate was stable for several days. The solution is to be thoroughly stirred prior to use.
- Fig. 1 Degradation of radioactive (A) and fluorescent (B) phospholipid in a phospholipase A 2 reaction.
- Enz. unit enzymatic activity, nanomoles lysophospholipid per minute and ml.
- the amount of enzyme used was varied and the enzymatic activity measured with both methods.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT81102650T ATE10112T1 (de) | 1980-04-09 | 1981-04-08 | Verfahren zur fluorimetrischen bestimmung der aktivitaet von fettspaltenden enzymen und mittel zur durchfuehrung dieses verfahrens. |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI801117A FI801117A7 (fi) | 1980-04-09 | 1980-04-09 | Rasvoja hajoittavien entsyymien aktiivisuuden määritys fluorometrisesti. |
| FI801117 | 1980-04-09 | ||
| FI801258 | 1980-04-18 | ||
| FI801258 | 1980-04-18 | ||
| FI810616 | 1981-02-27 | ||
| FI810616A FI63064C (fi) | 1980-04-09 | 1981-02-27 | Foerfarande foer fluorometrisk bestaemning av aktiviteten av fettspjaelkande enzymer och medel foer att genomfoera foerfarandet |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0037583A1 true EP0037583A1 (fr) | 1981-10-14 |
| EP0037583B1 EP0037583B1 (fr) | 1984-10-31 |
Family
ID=27241036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP81102650A Expired EP0037583B1 (fr) | 1980-04-09 | 1981-04-08 | Méthode pour la détermination fluorométrique de l'activité des enzymes dégradant les graisses et moyens pour sa réalisation |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4668623A (fr) |
| EP (1) | EP0037583B1 (fr) |
| CA (1) | CA1154453A (fr) |
| DE (1) | DE3166904D1 (fr) |
| FI (1) | FI63064C (fr) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3342106A1 (de) * | 1982-11-19 | 1984-06-14 | Toyo Jozo K.K., Tagata, Shizuoka | Komposition fuer lipase-bestimmung |
| EP0489839A4 (en) * | 1989-08-29 | 1992-10-28 | The Regents Of The University Of California | Novel hydrolytic enzyme inhibitors and substrates and assays, methods and kits embodying same |
| US5308766A (en) * | 1989-08-29 | 1994-05-03 | The Regents Of The University Of California | Hydrolytic enzyme inhibitors/inactivators and methods for using same |
| US5352673A (en) * | 1989-08-29 | 1994-10-04 | Dennis Edward A | Prodrugs |
| WO1995032181A1 (fr) * | 1994-05-19 | 1995-11-30 | Progen Biotechnik Gmbh | Determination par fluorescence de l'activite d'enzymes lipolytiques |
| GB2308189A (en) * | 1995-12-13 | 1997-06-18 | Univ Sunderland | Monitoring an enzyme involving a substrate therefor labelled with a fluorophore |
| WO2003069305A3 (fr) * | 2002-02-13 | 2004-04-01 | Wisconsin Alumni Res Found | Dosage de phospholipase fluorescent, inhibiteur et stimulateur de phospholipase a2, et utilisations |
| WO2003080554A3 (fr) * | 2002-03-27 | 2004-04-15 | Fuji Photo Film Co Ltd | Derive d'ester de glycerol |
| US7968306B2 (en) | 2002-02-13 | 2011-06-28 | Wisconsin Alumni Research Foundation | Method for measuring activity of a specific fraction of albumin |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3614647A1 (de) * | 1986-04-30 | 1987-11-05 | Euratom | 7-phenylessigsaeure-4-alkyl-coumarinylamide, verfahren zu ihrer herstellung sowie ihre verwendung in verfahren zur fluorometrischen bestimmung der aktivitaet von hydrolasen, insbesondere von penicillin-g-acylase |
| WO1990000618A1 (fr) * | 1988-07-08 | 1990-01-25 | Jbl Scientific, Inc. | Preparation et utilisation de derives de benzothiazole fluorescents |
| US5567596A (en) * | 1994-12-29 | 1996-10-22 | Research Foundation Of State University Of New York | Rapid assay of activators and inhibitors of clotting |
| US5908751A (en) * | 1996-04-26 | 1999-06-01 | Toyo Ink Mfg. Co., Ltd. | Method for detecting and/or determining ATP from microorganism cells in a sample |
| US6066446A (en) * | 1997-12-19 | 2000-05-23 | Nen Life Science Products, Inc. | Assay member and method for its manufacture |
| US5972595A (en) * | 1997-12-19 | 1999-10-26 | Nen Life Science Products, Inc. | Enzyme assay using a solid phase substrate |
| DE19919634C2 (de) * | 1999-04-30 | 2001-06-07 | Aventis Pharma Gmbh | Test zur Bestimmung der Integrität komplexer Phospholipid/Lipid-Strukturen mit Hilfe synthetischer fluoreszenz-markierter Acylglyceride und dessen Anwendung zur Bestimmung der Aktivität von Lipasen |
| JP4111669B2 (ja) | 1999-11-30 | 2008-07-02 | シャープ株式会社 | シート製造方法、シートおよび太陽電池 |
| WO2005005977A2 (fr) * | 2003-06-30 | 2005-01-20 | Applera Corporation | Dosages de phospholipases fluorescentes et compositions |
| US20050239217A1 (en) * | 2003-11-26 | 2005-10-27 | Applera Corporation | Fluorogenic homogeneous binding assay methods and compositions |
| CA2548407A1 (fr) * | 2003-12-12 | 2005-07-07 | Qtl Biosystems Llc | Essais, kits et reactifs de superextinction de fluorescence induite par des ions metalliques |
| WO2007012100A1 (fr) * | 2005-07-27 | 2007-02-01 | Technische Universität Graz | Phospholipides oxydes comportant un fragment de fluorophore et leur utilisation pour determiner la presence d'une enzyme a activite antiatherogene |
| RU2517746C1 (ru) * | 2012-11-22 | 2014-05-27 | Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) | Флуоресцентный зонд и тест-система для определения активности фосфолипазы а2 |
| CN103242474B (zh) * | 2013-05-08 | 2015-04-29 | 南京大学 | 磷酰胆碱结构修饰的苝酰亚胺衍生物及其制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR7600M (fr) * | 1967-04-14 | 1970-01-19 | ||
| US3741876A (en) * | 1970-08-06 | 1973-06-26 | Mason Res Inst Inc | Method of measuring enzyme reaction rates |
| US3986930A (en) * | 1974-05-28 | 1976-10-19 | Dainippon Pharmaceutical Co., Ltd. | Lipase activity determining method and reagent |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4261968A (en) * | 1979-05-10 | 1981-04-14 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| FI60700C (fi) * | 1980-04-09 | 1982-03-10 | Ksv Chemicals Oy | Foerfarande foer framstaellning av 1,2-diacyl-sn-glyceroler |
-
1981
- 1981-02-27 FI FI810616A patent/FI63064C/fi not_active IP Right Cessation
- 1981-04-08 CA CA000374931A patent/CA1154453A/fr not_active Expired
- 1981-04-08 EP EP81102650A patent/EP0037583B1/fr not_active Expired
- 1981-04-08 DE DE8181102650T patent/DE3166904D1/de not_active Expired
-
1984
- 1984-02-22 US US06/582,527 patent/US4668623A/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR7600M (fr) * | 1967-04-14 | 1970-01-19 | ||
| US3741876A (en) * | 1970-08-06 | 1973-06-26 | Mason Res Inst Inc | Method of measuring enzyme reaction rates |
| US3986930A (en) * | 1974-05-28 | 1976-10-19 | Dainippon Pharmaceutical Co., Ltd. | Lipase activity determining method and reagent |
Non-Patent Citations (2)
| Title |
|---|
| CHEMICAL ABSTRACTS, vol. 70, no. 15, April 14, 1969, page 28, abstract 64514y, COLUMBUS, OHIO (US) J.G. MEYER-BERTENRATH et al.: "Properties of new substrates for the determination of pancreas enzymes" & Z. Klin. Chem. Klin. Biochem., 6(6), 1968, 484-488 * |
| CHEMICAL ABSTRACTS, vol. 75, no. 17, October 25, 1971, page 27, abstract 105296c, COLUMBUS, OHIO (US) M. FLEISHER et al.: "Automated, fluorometric procedure for determining serum lipase" & Clin. Chem. 17(5), 1971, 417-422 * |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3342106A1 (de) * | 1982-11-19 | 1984-06-14 | Toyo Jozo K.K., Tagata, Shizuoka | Komposition fuer lipase-bestimmung |
| EP0489839A4 (en) * | 1989-08-29 | 1992-10-28 | The Regents Of The University Of California | Novel hydrolytic enzyme inhibitors and substrates and assays, methods and kits embodying same |
| US5308766A (en) * | 1989-08-29 | 1994-05-03 | The Regents Of The University Of California | Hydrolytic enzyme inhibitors/inactivators and methods for using same |
| US5352673A (en) * | 1989-08-29 | 1994-10-04 | Dennis Edward A | Prodrugs |
| US5427919A (en) * | 1989-08-29 | 1995-06-27 | The Regents Of The University Of California | Hydrolytic enzyme inhibitors/inactivators and methods for using same |
| WO1995032181A1 (fr) * | 1994-05-19 | 1995-11-30 | Progen Biotechnik Gmbh | Determination par fluorescence de l'activite d'enzymes lipolytiques |
| GB2308189A (en) * | 1995-12-13 | 1997-06-18 | Univ Sunderland | Monitoring an enzyme involving a substrate therefor labelled with a fluorophore |
| GB2308189B (en) * | 1995-12-13 | 1999-08-11 | Univ Sunderland | Method for monitoring enzymes |
| WO2003069305A3 (fr) * | 2002-02-13 | 2004-04-01 | Wisconsin Alumni Res Found | Dosage de phospholipase fluorescent, inhibiteur et stimulateur de phospholipase a2, et utilisations |
| US7579156B2 (en) | 2002-02-13 | 2009-08-25 | Wisconsin Alumni Research Foundation | Fluorescent phospholipase assay, phospholipase A2 inhibitor and stimulator, and the use thereof |
| US7968306B2 (en) | 2002-02-13 | 2011-06-28 | Wisconsin Alumni Research Foundation | Method for measuring activity of a specific fraction of albumin |
| WO2003080554A3 (fr) * | 2002-03-27 | 2004-04-15 | Fuji Photo Film Co Ltd | Derive d'ester de glycerol |
| US7371877B2 (en) | 2002-03-27 | 2008-05-13 | Fujifilm Corporation | Glycerol ester derivative |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0037583B1 (fr) | 1984-10-31 |
| DE3166904D1 (en) | 1984-12-06 |
| FI63064B (fi) | 1982-12-31 |
| CA1154453A (fr) | 1983-09-27 |
| US4668623A (en) | 1987-05-26 |
| FI810616L (fi) | 1981-10-10 |
| FI63064C (fi) | 1983-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0037583B1 (fr) | Méthode pour la détermination fluorométrique de l'activité des enzymes dégradant les graisses et moyens pour sa réalisation | |
| US6602657B1 (en) | Multiple reporter gene assay | |
| Dansette et al. | Continuous fluorometric assay of epoxide hydrase activity | |
| EP1151090B1 (fr) | Dosage multi-enzymatique | |
| Thuren et al. | Fluorometric assay for phospholipase A2 in serum. | |
| JP3413144B2 (ja) | 蛍光性ベンゾチアゾール誘導体の製法及び用途 | |
| Guilbault et al. | Fluorometric system employing immobilized cholinesterase for assaying anticholinesterase compounds | |
| US5585235A (en) | Fluorescent assay and method that corrects for spectral interference | |
| US6051391A (en) | Detection of microbial metabolites | |
| Bayburt et al. | Continuous, vesicle-based fluorimetric assays of 14-and 85-kDa phospholipases A2 | |
| CN102388311A (zh) | 用于定量测定样品中磷脂酶a1或a2活性的酶测定法 | |
| Zaikova et al. | Synthesis of fluorogenic substrates for continuous assay of phosphatidylinositol-specific phospholipase C | |
| US4962024A (en) | Signal enhancement in assay for an enzyme | |
| US5512429A (en) | Assay for enzyme activity | |
| US4777269A (en) | 7-Phenylacetic acid-4-alkyl-coumarinyl amides useful in fluorometric determination of the activity of hydrolases | |
| JP4365026B2 (ja) | ジヒドロキシ芳香族化合物と複素環式エノールホスファートを使用した化学発光反応 | |
| Wolf et al. | A sensitive assay of phospholipase using the fluorescent probe 2-parinaroyllecithin | |
| Kinkaid et al. | Phospholipase D and phosphatidic acid enhance the hydrolysis of phospholipids in vesicles and in cell membranes by human secreted phospholipase A2 | |
| Zandonella et al. | Enantiomeric perylene‐glycerolipids as fluorogenic substrates for a dual wavelength assay of lipase activity and stereoselectivity | |
| US4784945A (en) | Method for determining lipids | |
| Kurnick et al. | Acid desoxyribonuclease assay by the methyl green method | |
| AU639489B2 (en) | Assay for enzyme activity | |
| Moreau | An evaluation of NBD-phospholipids as substrates for the measurement of phospholipase and lipase activities | |
| SIEGEL et al. | The kinetics of cholinesterases measured fluorometrically | |
| Shashidhar et al. | A fluorescent substrate for the continuous assay of phosphatidylinositol-specific phospholipase C: synthesis and application of 2-naphthyl myo-inositol-1-phosphate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| AK | Designated contracting states |
Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
| 17P | Request for examination filed |
Effective date: 19820211 |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: KSV-CHEMICALS OY |
|
| ITF | It: translation for a ep patent filed | ||
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
| REF | Corresponds to: |
Ref document number: 10112 Country of ref document: AT Date of ref document: 19841115 Kind code of ref document: T |
|
| REF | Corresponds to: |
Ref document number: 3166904 Country of ref document: DE Date of ref document: 19841206 |
|
| ET | Fr: translation filed | ||
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19850430 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| 26N | No opposition filed | ||
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 19860428 Year of fee payment: 6 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 19870430 Year of fee payment: 7 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Effective date: 19890408 Ref country code: AT Effective date: 19890408 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Effective date: 19890409 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Effective date: 19890430 Ref country code: CH Effective date: 19890430 Ref country code: BE Effective date: 19890430 |
|
| BERE | Be: lapsed |
Owner name: KSV-CHEMICALS OY Effective date: 19890430 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Effective date: 19891101 |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee | ||
| NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee | ||
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19891228 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Effective date: 19900103 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
| EUG | Se: european patent has lapsed |
Ref document number: 81102650.9 Effective date: 19900412 |